Emmanuel Thomas

Emmanuel Thomas M.D.,Ph.D.,FAASLD-Translational Medicine &Therapeutics, Virus/HCV Elimination, COVID-19/SARS-CoV-2, Viral Hepatitis, HCC/Liver Cancer, ALF

[Emmanuel Thomas @Emmanuel_Thomas]

Our NEW animated Bili the Brave video from American Liver Foundation

Bili the Brave is a heartwarming animated story helping children understand biliary atresia through courage, community, and the power of a roar.

https://t.co/DXL5TAKBIK

[HCV Free Florida @HCVFreeFL]

Join colleagues and leading experts for the next installment of the Florida Viral Hepatitis Network- Hepatitis Elimination Series: https://t.co/7ZT0NpFO4h

[American Liver Foundation National @liverUSA]

American Liver Foundation (ALF) is deeply disappointed that the Advisory Committee on Immunization Practices (ACIP) voted this morning to end the highly effective universal hepatitis B (hep B) birth dose recommendation for infants. Read our full statement: https://t.co/yoYSDhFyu2

#HepatitisB #ProtectInfants #VaccinesSaveLives #LiverHealth #viralhepatitis
#AmericanLiverFoundation

[American Liver Foundation National @liverUSA]

American Liver Foundation sends our heartfelt well wishes to former NFL quarterback Bernie Kosar as he begins his recovery following his liver transplant.

After a long and challenging wait for a donor organ, we’re relieved and inspired to see Bernie come through surgery with optimism and strength. His story is a powerful reminder of the life-saving impact of organ donation and the incredible gift that liver transplantation provides. Read more about Bernie’s journey: https://t.co/lVzoCImq4o

#OrganDonation #LiverHealth #TransplantJourney #DonateLife #LiverTransplant #DonateLife

https://t.co/lVzoCImq4o

[HCV Free Florida @HCVFreeFL]

Register for Webinar One of the Florida Viral Hepatitis Network: Hepatitis Elimination Series https://t.co/6Xp5hTahzf

[American Liver Foundation National @liverUSA]

Watch our conversation about the changes in terminology for Steatotic Liver Disease and what this means for patients with Rotonya Carr, MD, FACP. https://t.co/EQFNFGbNTA

[American Liver Foundation National @liverUSA]

We are honored to award Benjamin Samstein, MD, Professor of Surgery Chief of Liver Transplant & Hepatobiliary and Pancreatic Surgery New York Presbyterian Hospital – Weill Cornell Medicine with the Leadership Award at our National Legacy Gala on October 29th.

Dr. Samstein is deeply admired for his clinical expertise, innovative contributions to advancing the field of living donor liver transplantation, and dedication to improving the lives of liver patients everywhere.

Read more about his work and how you can join him in New York City here: https://t.co/NczMu1h5f2

[American Liver Foundation National @liverUSA]

American Liver Foundation’s National Legacy Gala returns to Gotham Hall, NYC on Oct. 29. The evening will include a reception, a silent and live auction, and a dinner featuring a presentation honoring inspiring individuals who have made outstanding contributions to the liver community in the fields of biotechnology, medical innovation, and philanthropy.

“ALF’s National Legacy Gala is a beautiful evening of celebration as we honor the contributions of our esteemed 2025 award recipients,” said Lorraine Stiehl, CEO, American Liver Foundation.

Learn more about the honorees and awardees, as well as how you can purchase tickets or participate in the auction here: https://t.co/ibN0Dsw9db.

[American Liver Foundation National @liverUSA]

NFL legend Dan Marino just revealed he’s living with metabolic dysfunction-associated steatohepatitis, also known as MASH — a serious liver disease caused by fat buildup and inflammation.

The good news? With early diagnosis, diet changes, and support, it’s manageable — even reversible. His message: “Don’t wait. Get checked.”

Read more about Marino's journey.

#LiverHealth #DanMarino #MASHawareness #FattyLiver #MASH #NASH #NFL
https://t.co/vw8722gJvQ

[American Liver Foundation National @liverUSA]

We're excited to announce the launch of the ALF Living Donor Network, the first-ever national database for non-directed (also called altruistic) living donors.

With nearly 9,300 people in the U.S. waiting for a liver transplant - and 25% at risk of dying while waiting - this secure database addresses a critical shortage of donors in the U.S. and connects willing donors with transplant centers across the country to help adult and pediatric patients in need.
Whether you're a transplant professional or someone ready to give the gift of life, this network is a game-changer.

Learn more and register today: https://t.co/dxAvVpp1Rk

#LivingDonorNetwork #OrganDonation #GiftOfLife #LiverTransplant #DonateLife #LDLT

[American Liver Foundation National @liverUSA]

We are honored to have Richard J. Miller JR. Esq as our Gala Chair at our National Legacy Gala on October 29th! Learn more about Richard's journey with liver disease and transplantation, as well as his involvement with American Liver Foundation: https://t.co/D7RrUiGvNf

[EASLnews @EASLnews]

EASL is deeply saddened to share the news of the passing of Professor Michael P. Manns (1951–2025).

A visionary leader in hepatology, Professor Manns shaped the field through his pioneering research in viral hepatitis, autoimmune liver diseases, transplantation and regenerative medicine. He served as Director of the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School for nearly three decades, and held leading roles in Hep-Net, the German Liver Foundation, UEG, and EASL.

His scientific excellence, dedication and mentorship inspired colleagues around the world. Professor Manns received numerous awards, including the EASL Recognition Award (2007) and the UEG Lifetime Achievement Award (2022).

EASL extends heartfelt condolences to his family, friends and colleagues. His legacy will continue to inspire generations of hepatologists.

[CDC Hepatitis @cdchep]

#HCPs: Most people with #HepatitisC have no symptoms. Make universal screening a part of your practice. Learn more: https://t.co/ZeCeiHDmQP

[Emmanuel Thomas @Emmanuel_Thomas]

World Hepatitis Day is aiming for a world without viral hepatitis
https://t.co/gYCqrgJfuu

[AASLD @AASLDtweets]

Don’t miss our free virtual #Hepatitis B & C updates webinar, 7/31 at 10 AM ET! Join AASLD & @INASL for the latest on @WHO goals, HCC management, & hep B treatment advances. Register now: https://t.co/pJ6x9SzUnG

#WorldHepatitisDay #LiverHealth #AASLD

[American Liver Foundation National @liverUSA]

Today is #WorldHepatitisDay - powerful reminder that knowledge is prevention. #Viralhepatitis is one of the leading causes of #livercancer worldwide, yet it’s often misunderstood. Our latest video explores the connection. Watch now & help spread awareness! https://t.co/QCikyyIa56

[HCV Free Florida @HCVFreeFL]

Excited about this new opportunity from SAMHSA to fund HCV elimination pilot grants!
https://t.co/LnF6BAhFY8

[American Liver Foundation National @liverUSA]

Join us for our presentation “The Connection Between #ViralHepatitis & #LiverCancer” on Thursday, 5/28 at noon EST. We will be joined by joined by expert speakers Emmanuel Thomas, MD, PhD, FAASLD, ALF Board Chair & Associate Professor at University of Miami (1/2)

[Carlos E Alfonso, MD FACC FSCAI @CarlosAlfonsoMD]

Grateful for my time @UMiamiHealth, now onward to new frontiers, I am proud to join the outstanding cardiovascular team @BaptistHealthSF as Director of the chronic total occlusion & complex PCI program working closely with our amazing team to take it to the next level!

[Journal of Clinical Investigation @jclinicalinvest]

Tapping ancient viral DNA in the treatment of glioblastoma!

@AshishHShah4 @SeetharamDeepa @jaychandar5 & team @umiamimedicine show the zinc finger protein ZNF638 activates viral mimicry to promote immune checkpoint inhibition in preclinical models of glioblastoma: https://t.co/YXXZkcs4eH